MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-518

  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    I am sure the FDA doesn't give a damn about what SI "says" but in what he has presented.....which so far isn't very convincing. obviously.

    he's failed Stem Cell 101 after 17 years!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.